1. FADD as a key molecular player in cancer progression
   Ying Liu et al, 2022, Molecular Medicine CrossRef
2. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma
   José L Marín-Rubio et al, 2019, Carcinogenesis CrossRef
3. Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients
   Nelson Inácio Pinto Neto et al, 2019, Oncotarget CrossRef
4. FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications
   José L Marín-Rubio et al, 2019, Cancers CrossRef
5. Identification of Autophagy-Related Gene Signature as A Prognostic Index in Patients Suffering from Head and Neck Squamous Cell Carcinoma
   Chao Guo et al, 2023, Journal of Biomedical Nanotechnology CrossRef
6. Peritumoural adipose tissue pro‐inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients
   Nelson Inácio Pinto Neto et al, 2018, Journal of Cachexia, Sarcopenia and Muscle CrossRef
7. MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells
   Cheng Wang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
8. Bioinformatic Prediction of Possible Targets and Mechanisms of Action of the Green Tea Compound Epigallocatechin-3-Gallate Against Breast Cancer
   Xinqiang Song et al, 2017, Frontiers in Molecular Biosciences CrossRef
9. Cancer-related proteins in serum are altered in workers occupationally exposed to polycyclic aromatic hydrocarbons: a cross-sectional study
   Ayman Alhamdow et al, 2019, Carcinogenesis CrossRef
10. SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer
    Jie Luo et al, 2018, Biochemical and Biophysical Research Communications CrossRef